Skip to main content
Vivimed Labs Ltd. logo

Vivimed Labs Ltd. — Investor Relations & Filings

Ticker · VIVIMEDLAB ISIN · INE526G01021 LEI · 335800LYN9TN3F87WV86 BSE.NS Manufacturing
Open in API
Filings indexed 861 across all filing types
Latest filing 2024-05-17 Regulatory Filings
Country IN India
Listing BSE.NS VIVIMEDLAB

About Vivimed Labs Ltd.

http://www.vivimedlabs.com/

Vivimed Labs Ltd. specializes in the development and manufacture of active pharmaceutical ingredients (APIs), finished dosage formulations (FDF), and specialty chemicals. The company provides contract research and manufacturing services (CRAMS) and produces generic medicines across various therapeutic areas. Its specialty chemicals division focuses on niche products, including photochromic dyes for ophthalmic lenses, hair colorants, and anti-microbial agents for personal care and industrial use. Vivimed operates research and development centers and manufacturing facilities that adhere to international regulatory standards, catering to a global customer base in the healthcare and chemical sectors.

Recent filings

Filing Released Lang Actions
The Board Meeting to be held on 20/05/2024 Stands Cancelled.
Regulatory Filings
2024-05-17 English
Board Meeting — VIVIMED LABS LIMITED has informed the Exchange about Board Meeting to be held on 20-May-2024 to inter-alia consider and approve the Audited Financial results of the Company for the Ye…
Regulatory Filings
2024-05-10 English
Board Meeting — Financial Results
Board/Management Information Classification · 95% confidence The document is a notice of a Board Meeting scheduled to approve audited financial results for the quarter and year ended 31 March 2024. It also mentions the closure of the trading window for insiders. The document is short (1849 characters) and serves as an announcement of the meeting and trading window closure, not the financial results themselves. It references regulatory compliance under SEBI listing obligations and insider trading regulations. This fits the category of Board/Management Information (MANG) because it announces a board meeting and related compliance information, rather than providing the actual financial report or results.
2024-05-08 English
VIVIMED LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2024 ,inter alia, to consider and approve Notice of Board Meeting / Closure ....
Regulatory Filings
2024-05-08 English
Change in Corporate Office Address
Regulatory Filings
2024-05-04 English
Address Change
Regulatory Filings Classification · 100% confidence The document text contains only placeholders for images and no substantive text or financial data. The true document length is only 113 characters, indicating it is extremely short and does not contain any report content. There is no indication of any report, announcement, or filing type. Given the lack of content, this document does not fit any specific report category and defaults to Regulatory Filings (RNS) as a fallback category.
2024-05-04 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.